Eliana Clark, EVP, Chief Technical Officer at Intellia Therapeutics, Inc. (NTLA), sold 15,400 shares at $12.18 ($187K) on 2025-01-03, disclosed to the SEC on 2025-01-06.
Open-market sale of $187k NTLA by EVP, Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.03 | 556 | $7K | 3.6% |
| 2 | $12.18 | 7,422 | $90K | 48.2% |
| 3 | $12.18 | 7,422 | $90K | 48.2% |
| Total | $12.17 avg | 15,400 | $187K | 100% |
| Filing → |
| NTLA | SELL | 2025-07-03 | $10K | — | Filing → |
| NTLA | SELL | 2025-03-04 | $6K | — | Filing → |
| NTLA | SELL | 2024-07-03 | $9K | — | Filing → |